Matches in Wikidata for { <http://www.wikidata.org/entity/Q63595473> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q63595473 description "clinical trial" @default.
- Q63595473 description "ensayu clínicu" @default.
- Q63595473 description "klinisch onderzoek" @default.
- Q63595473 description "клінічне випробування" @default.
- Q63595473 description "կլինիկական փորձարկում" @default.
- Q63595473 name "A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer." @default.
- Q63595473 type Item @default.
- Q63595473 label "A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer." @default.
- Q63595473 prefLabel "A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer." @default.
- Q63595473 P1132 Q63595473-BE0608D3-FECE-4B87-934B-C1561F87A2FA @default.
- Q63595473 P1476 Q63595473-C26A337F-0CEA-4275-9778-F15B53F177C8 @default.
- Q63595473 P2899 Q63595473-3FC56015-F073-4C1E-9556-995C6EDA8D2A @default.
- Q63595473 P3098 Q63595473-7C35BEFD-6EA0-4CC0-9822-448B9B6A1198 @default.
- Q63595473 P31 Q63595473-12BB3456-A67F-4EF7-90FD-C9EF2C612858 @default.
- Q63595473 P4844 Q63595473-A52A8BB4-5079-4583-BA67-FBDD688BE849 @default.
- Q63595473 P4844 Q63595473-B867D348-BFC3-4C18-ACD7-30367AFCCA9D @default.
- Q63595473 P580 Q63595473-0957D96D-4D67-4848-9BF7-21AB996210CD @default.
- Q63595473 P582 Q63595473-CF63B15F-7199-45BD-AD5D-1E3B1E421EFE @default.
- Q63595473 P6099 Q63595473-BB9FAFA3-243C-4D79-BE51-BBBC64DAB133 @default.
- Q63595473 P6153 Q63595473-B290BF83-4EAB-4792-A99F-D2040013AAB5 @default.
- Q63595473 P6153 Q63595473-DCB74C87-8162-43AF-8E13-B22B0BAA02CF @default.
- Q63595473 P8363 Q63595473-1BCFDE06-07F5-4C89-A379-DB611E69633C @default.
- Q63595473 P1132 "+48" @default.
- Q63595473 P1476 "A Phase Ib, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Humanized Anti-VEGF Monoclonal Antibody(Sevacizumab) Injection Plus Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer." @default.
- Q63595473 P2899 "+18" @default.
- Q63595473 P3098 "NCT03763123" @default.
- Q63595473 P31 Q30612 @default.
- Q63595473 P4844 Q419953 @default.
- Q63595473 P4844 Q423762 @default.
- Q63595473 P580 "2018-04-24T00:00:00Z" @default.
- Q63595473 P582 "2019-12-31T00:00:00Z" @default.
- Q63595473 P6099 Q5452194 @default.
- Q63595473 P6153 Q11124475 @default.
- Q63595473 P6153 Q30253707 @default.
- Q63595473 P8363 Q78089383 @default.